Want to join the conversation?
$NRG 2Q15 PR: Total operating revenues for the full year 2014 were $15,868MM compared to $8,422MM in full year 2012. Net income for full year 2014 was $134MM compared to $315MM in full year 2012. Operating income for full year 2014 was $1,271MM compared to $350MM in full year 2012.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.